Articles From: U.S. stocks: Futures bruised by continued oil selloff to Galena Biopharma Reports Third Quarter 2014 Results


2014/12/12
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.S. stock futures pointed to a red open on Wall Street on Friday, as a further slump in oil prices continued to dampen the investment mood and fanned fears of an imminent stock-market correction.
Sign-up for U.S. stocks: Futures bruised by continued oil selloff investment picks
2015/1/8
By David Benoit And Jacob Bunge Nelson Peltz's investment firm launched a fight against DuPont Co.
Sign-up for Trian Seeks Four Seats on DuPont's Board--update investment picks
ST. PAUL, Minn.
Sign-up for CHS posts fiscal 2014 earnings of $1.1 billion; Second highest in history investment picks
Dexcom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the U.S. Food and Drug Administration (FDA) has approved new software for the Dexcom G4 ® PLATINUM CGM.
Sign-up for FDA Approves Dexcom Software with Artificial Pancreas Algorithm investment picks
NEW YORK , Oct.
Sign-up for Morgan & Morgan Announces the Investigation of Digital River -- DRIV investment picks
2014/12/18
BEIJING , Dec.
Sign-up for China New Borun to Hold Annual General Meeting on January 16, 2015 investment picks
CLEVELAND, Oct.
Sign-up for TFS Financial Corporation's Earnings Highest Since 2007 IPO investment picks
Aeterna Zentaris to Present at Upcoming Biotech Showcase Conference in San Francisco Canada NewsWire QUÉBEC CITY, Jan.
Sign-up for Aeterna Zentaris to Present at Upcoming Biotech Showcase Conference in San Francisco investment picks
HOUSTON , Nov.
Sign-up for Harvest Natural Resources Announces 2014 Third Quarter Results investment picks
Vascular Solutions will distribute two models of the ZigiWire guidewire system, a novel support wire system designed for gaining vascular access in both simple and challenging peripheral intervention ZigiWire is developed and manufactured by VadisWire Corp.
Sign-up for Vascular Solutions Announces FDA 510(k) Clearance of Zigiwire(TM) Access Guidewire System investment picks
Creates World's Largest Solar Cell Manufacturer Achieves Global Scale to Drive Competitiveness and Expansion in Key Geographies Unlocks Revenue and Cost Synergies through Combination of Complementary Businesses SHANGHAI, China and THALHEIM, Germany , Dec.
Sign-up for Hanwha SolarOne and Q CELLS Announce Merger to Create New Solar Power Leader investment picks
2014/11/5
Most of the sentiment around Tesla Motors Inc. earnings is "nervous/cautious," analysts at Morgan Stanley said in a note Wednesday.
Sign-up for UPDATE: Investors 'nervous' about Tesla earnings: Morgan Stanley investment picks
2015/1/1
By Anita Rachman And Jake Maxwell Watts SURABAYA, Indonesia--The families of many of the 162 people presumed dead in the crash of the AirAsia plane spent New Year's Day waiting anxiously as the few bodies recovered so far began to be returned to their hometown.
Sign-up for Christian Community Takes Heavy Blow in AirAsia Crash investment picks
Company to focus on under-served New Jersey housing market, primarily in Monmouth, Middlesex, Union, and Ocean Counties Hires Scott Keller as Senior Vice President – Residential Mortgage Division Company to report 2014 third quarter financial results on Tuesday, October 21, 2014 TINTON FALLS, N.J., Oct.
Sign-up for Two River Bancorp Announces Expansion of Residential Mortgage Operations investment picks
Small business owners are increasingly guarded with respect to their business activities through year-end, but many express a more optimistic view concerning their business plans for 2015, according to the most recent Business Confidence Survey released today by Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses.
Sign-up for Small Businesses Increasingly Cautious, but Anticipate a Better 2015, According to Insperity Survey investment picks
NEW YORK , Oct.
Sign-up for Dice Holdings, Inc. Reports Third Quarter 2014 Results investment picks
2014/11/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978176001&sourceType=1 http://media3.marketwire.com/logos/20141110-centuryiron200.jpg http://www.marketwire.com/library/20141110-978176_ICM_NFL_300.jpg Sandy Chim (L), Chairman of Labec Century Iron Ore Inc., and President and CEO of Century Iron Mines Corporation receiving the 2014 Explorer of the Year Award from George Ogilvie (R), President of CIM - Newfoundland Branch.
Sign-up for Labec Century Awarded the 2014 Explorer of The Year Award, CIM Newfoundland Branch investment picks
American Tower Corporation (NYSE: AMT) today announced that its Executive Vice President, International Operations and President, Latin America and EMEA, Hal Hess, is scheduled to present at the 14 th Annual Morgan Stanley European Technology, Media & Telecoms Conference in Barcelona, Spain, on Friday, November 21, 2014 at 8:05 a.m. CET (2:05 a.m. ET). The live audio webcast link will be available on the Company's website, www.americantower.com .
Sign-up for American Tower Corporation to Present at the 14th Annual Morgan Stanley European Technology, Media & Telecoms Conference investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta Announces FDA’s Oncologic Drugs Advisory Committee to Discuss Pediatric Uses for Ganetespib investment picks
NEW YORK, Nov.
Sign-up for StoneCastle Financial Corp. Reports Third Quarter 2014 Results investment picks
-- Isis Earns $27 Million Milestone Payment --
Sign-up for Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy investment picks
PPG Industries (NYSE:PPG) today announced that Marcos Achar Levy, previously chief executive officer of Comex, has been appointed vice president, architectural coatings, Mexico, and CEO, PPG – Comex.
Sign-up for PPG Appoints Marcos Achar Levy Vice President, Architectural Coatings, Mexico investment picks
VANCOUVER, British Columbia, Oct.
Sign-up for QLT Announces Third Quarter 2014 Results investment picks
Bemis Company, Inc. (NYSE:BMS) today reported third quarter 2014 diluted earnings per share from continuing operations of $0.61 per share, compared to $0.47 per share for the same quarter of 2013.
Sign-up for Bemis Company Reports Record EPS from Continuing Operations for Third Quarter 2014 investment picks
Clinical programs advance on multiple fronts, with trial initiation, trial enrollment, data and IP milestones achieved and anticipated Commercial strategy reinforced with product acquisition and upcoming commercial launch Abstral ® (fentanyl) sublingual tablet net revenue was $1.6 million in Q3 2014 and $6.1 million to date this year, with reiterated guidance of $8-$10 million for the full year 2014 Zuplenz ® (ondansetron) Oral Soluble Film U.S. rights licensed; launch expected in Q1 2015 Conference call scheduled for 5:00 pm E.T. today with details below PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Reports Third Quarter 2014 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: U.S. stocks: Futures bruised by continued oil selloff to Galena Biopharma Reports Third Quarter 2014 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent